-
Business
From Beyoncé To NFL: Can Netflix Cement Its Sports Streaming Legacy?
The flawless execution of the NFL games on Christmas Day demonstrated the strides Netflix has made in upgrading its content…
Read More » -
Business
Could Lionsgate Be Hollywood’s Next Big Buy? Top Reasons It’s on Every Investor’s Radar
The entertainment landscape is buzzing with speculation following recent reports that activist investor Anson Funds Management has taken a strategic…
Read More » -
Business
Could Logility Be the Next Big Supply Chain Tech Buyout? Here’s Why Investors Should Pay Attention
Logility Supply Chain Solutions has recently attracted significant attention following a call from its shareholder, 2717 Partners, urging the company’s…
Read More » -
Market Movers
Microsoft Is Betting Big on NVIDIA GPUs — But Will Custom Chips Save Its AI Ambitions?
Microsoft has secured nearly half a million Nvidia GPUs in 2024 alone, surpassing rivals Google, Amazon, and Meta given its…
Read More » -
Business
Honeywell’s Future Hangs In The Balance: Elliott’s $5 Billion Push For A Breakup
Honeywell International is now at the center of a heated debate following activist investor, Elliott Investment Management’s call for a…
Read More » -
Business
Honda & Nissan Eye Historic Merger Amid Foxconn’s Surprise Move – What You Need to Know!
The automotive world is abuzz with news of a potential landmark merger between Honda and Nissan, signaling what could be…
Read More » -
Market Movers
SMCI Investigation Sparks Rally—Should Investors Be Concerned About Lingering Issues?
SMCI’s shares surged after an independent investigation found no evidence of fraud and the special committee's recommendation to strengthen governance…
Read More » -
Business
GM’s $1 Billion Stake Sale: Is the Carmaker Rethinking Its Battery Strategy?
GM has recently been in the news after it announced the sale of its stake in a $2.6 billion battery…
Read More » -
Biotech
The Biotech Stock Soaring 63% on Unprecedented Cancer Trial Results – Meet Janux Therapeutics
On December 3, 2024, the company announced groundbreaking results for its lead drug candidate, JANX007, a tumor-activated T-cell engager targeting…
Read More » -
Business
Is MicroStrategy’s Bitcoin Frenzy Setting It Up For A Crash?
MicroStrategy has been making headlines once again, fueled by its audacious Bitcoin-centric strategy and a meteoric stock price rise of…
Read More »
